跳至主要内容
临床试验/NCT05347927
NCT05347927已完成不适用

Exploratory, Prospective, Multicenter, Observational Study to Evaluate the Influence of Undercast Material Types on Skin Microbiome

BSN Medical GmbH3 个研究点 分布在 1 个国家目标入组 108 人开始时间: 2022年10月30日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
108
试验地点
3
主要终点
products´ influence on skin microbiome during fracture management

研究概览

简要总结

This clinical study will evaluate the clinical performance and the safety of the CE-marked casting and padding materials when used in routine fracture care without any additional invasive methods and within the intended use. As primary objective the cast therapy´s influence on skin microbiome during fracture management will be investigated. Further, the influence of the padding material on the skin microbiome, device comfort, skin conditions, and impact on daily life activities as well as HCP´s and patient´s satisfaction and general product safety and performance are considered as secondary outcomes.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject ≥ 18 years of age
  • Patient is physically and mentally able to participate in this study
  • Proper understanding of the Dutch language
  • Signed informed consent
  • Fractures to be treated with a short-arm cast without thumb inclusion for the period of 3 weeks (e.g. 2R3A1 = radial styloid avulsion, 2R3A2 = Simple radial fracture, 2U3A1 = Ulnar fracture of the base of the styloid process, 2U3A2= Simple distal ulna fracture, 2R3B1 = Intraarticular fracture of the styloid process of the radius (not displaced) or Triquetrum fracture (non AO classified))

排除标准

  • Subject <18 years of age
  • Pregnancy, breast feeding
  • Participation in other clinical trials
  • Patient is neither physically nor mentally able to participate in this study
  • Non-intact skin in treatment area (including dermatological issues)
  • Patients with impaired (e.g. Cortisone skin, extremely dry skin, parchment skin) or damaged skin with either a surgical wound or a traumatic wound
  • Medical treatment prior casting which could influence the microbiome
  • Known Blood Circulatory Diseases
  • Known Lymphedema or any general disorder of the lymphatic system
  • Known Osteoporosis
  • Known Diabetes
  • Knowing of one of the following illnesses that might require regular systemic medication: cancer, rheumatic disease
  • Intolerability or documented allergies against cast materials
  • Subjects with not "normal" (unusual) hygienic behavior
  • Suspected drug addiction or alcohol abuse
  • Patients diagnosed HIV-positive or with infectious hepatitis based on self-declaration by subjects

结局指标

主要结局

products´ influence on skin microbiome during fracture management

时间窗: 3 weeks

Beta diversity skin microbiome

次要结局

  • Treatment comfort(3 weeks)
  • Number of adverse events during study per product(3 weeks)
  • General product performance(3 weeks)
  • Impact on daily life activities(3 weeks)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验